Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to our new ARUK Clinical Research Fellows, Dr Malvika Gulati and Miss Jennifer Lane on their successful Fellowship applications.

Jennifer will be studying the “Epidemiology of common hand conditions”. The project will study trends in disease variation and the surgical management of the condition at a national level using routinely collected UK GP and hospital data. Two large research studies, UK Biobank and the Million Women Study, will also be used to study over 1.8 million people to consider risk factors in developing severe osteoarthritis.

Commenting on the news of her successful application Jennifer stated “I'm thrilled to be working with ARUK for this project that I hope will help us better understand why people develop hand conditions, and aid us in determining the best surgical treatments for the future."

Jennifer will be sponsored by Prof Dominic FurnissProf Daniel Prieto-Alhambra and Prof Jane Green at the Million Women Study based in the Cancer Epidemiology Unit at the Nuffield Department of Population Health.

Dr Malvika Gulati will be looking at ”The role of gender, menopause and sex hormones in painful hand osteoarthritis (OA)”. Hand OA is common, affecting 2 million people in the UK and can cause pain, swelling and deformity and has greater occurrences in women. The project aims to improve understanding of the role of gender and hormonal influences in the pathogenesis of painful hand OA, in order to predict individual outcomes and identify new treatment strategies.

On acceptance of the award Malvika stated "I am grateful for the opportunity that Arthritis Research UK has given us. Hand osteoarthritis is the most common form of arthritis in the hand, yet treatment options are limited. This funding will allow us to better understand the condition and test our hypothesis that hormones may play a role in its development.”  

Malvika will be sponsored by Prof Fiona WattProf Tonia Vincent and Prof Nigel Arden.

FUNDING BODY

New funding for arthritis research

Similar stories

Professor Michael Dustin appointed new Chair in Molecular Immunology

A generous gift from the Kennedy Trust for Rheumatology Research has enabled the creation of a new Chair in Molecular Immunology at the University of Oxford.

The Kennedy’s research strongly endorsed following independent review

We recently welcomed our Scientific Advisory Board (SAB) and the Kennedy Trust Scientific Review Board (TSRB) to the Institute to review our current activities and future plans.

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.

Mathematician boosts data science research at the Kennedy Institute

Welcome to Yang Luo who has joined the Kennedy Institute as the Principal Investigator of the Luo Group. Her lab is leading the investigation into how genetic variations contribute to diseases of the immune system.

NIHR funding for musculoskeletal and inflammatory disease research

Health and care research in Oxford is to receive £122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients.

Leducq Foundation grant boosts cardiovascular research

The Leducq Foundation has awarded $7.5 million to researchers at the University of Oxford and their collaborators to advance immunotherapy as a treatment for cardiovascular disease, the leading cause of death in the UK.